Loading...
Loading...
Landec Corporation
LNDC, a materials science company that develops and markets
innovative and patented products for food and biomedical applications, today
announced that certain customers of its wholly-owned biomaterials subsidiary,
Lifecore Biomedical, Inc., have requested that shipments originally planned to
be shipped in November be shipped in December, which will result in revenues
and profits planned for the second quarter being recognized in the third
quarter. Therefore, approximately $3.0 million of gross profit is being
shifted from Landec's second fiscal quarter to Landec's third fiscal quarter.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in